| Secondary |
| Product Used For Unknown Indication |
40.7% |
| Drug Use For Unknown Indication |
18.9% |
| Psychotic Disorder |
7.3% |
| Schizophrenia |
5.9% |
| Foetal Exposure During Pregnancy |
3.9% |
| Abnormal Behaviour |
2.9% |
| Anxiety |
2.5% |
| Depression |
2.2% |
| Insomnia |
2.2% |
| Autism |
1.9% |
| Schizophrenia, Paranoid Type |
1.9% |
| Agitation |
1.6% |
| Epilepsy |
1.2% |
| Drug Exposure During Pregnancy |
1.2% |
| Ill-defined Disorder |
1.2% |
| Bipolar I Disorder |
1.1% |
| Extrapyramidal Disorder |
1.0% |
| Parkinsonism |
1.0% |
| Bipolar Disorder |
0.8% |
| Maternal Exposure Timing Unspecified |
0.8% |
|
| Vomiting |
14.0% |
| Tachycardia |
8.5% |
| Pulmonary Embolism |
7.0% |
| Suicide Attempt |
6.2% |
| Urinary Retention |
6.2% |
| Thrombocytopenia |
5.4% |
| Bradycardia |
4.7% |
| Sepsis |
4.7% |
| Somnolence |
4.7% |
| Tremor |
4.7% |
| Hypoglycaemia |
3.9% |
| Intestinal Obstruction |
3.9% |
| Peripheral Sensory Neuropathy |
3.9% |
| Pyrexia |
3.9% |
| Colitis Ischaemic |
3.1% |
| Eosinophilia |
3.1% |
| Hyperprolactinaemia |
3.1% |
| Lymphocytosis |
3.1% |
| Lymphoedema |
3.1% |
| Renal Failure |
3.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
28.7% |
| Drug Use For Unknown Indication |
16.8% |
| Psychotic Disorder |
10.8% |
| Schizophrenia |
10.8% |
| Depression |
3.8% |
| Anxiety |
3.1% |
| Persecutory Delusion |
2.8% |
| Bipolar Disorder |
2.7% |
| Insomnia |
2.6% |
| Abnormal Behaviour |
2.4% |
| Hepatitis C |
2.0% |
| Atrial Fibrillation |
1.8% |
| Schizophrenia, Paranoid Type |
1.8% |
| Agitation |
1.7% |
| Parkinsonism |
1.7% |
| Bipolar I Disorder |
1.4% |
| Embolism |
1.4% |
| Extrapyramidal Disorder |
1.3% |
| Hypertension |
1.2% |
| Delirium |
1.0% |
|
| Pulmonary Embolism |
7.4% |
| Tremor |
7.4% |
| Vomiting |
7.4% |
| Electrocardiogram Qt Prolonged |
6.7% |
| Tricuspid Valve Incompetence |
6.7% |
| Rhabdomyolysis |
5.9% |
| Weight Decreased |
5.2% |
| Cerebellar Syndrome |
4.4% |
| Cholestasis |
4.4% |
| Death |
4.4% |
| Neutropenia |
4.4% |
| Psychiatric Decompensation |
4.4% |
| Respiratory Disorder |
4.4% |
| Treatment Noncompliance |
4.4% |
| Cytolytic Hepatitis |
3.7% |
| Fall |
3.7% |
| Inappropriate Schedule Of Drug Administration |
3.7% |
| Malaise |
3.7% |
| Off Label Use |
3.7% |
| Orthostatic Hypotension |
3.7% |
|
| Interacting |
| Product Used For Unknown Indication |
38.5% |
| Bipolar Disorder |
30.8% |
| Bipolar I Disorder |
20.5% |
| Psychotic Disorder |
5.1% |
| Tremor |
5.1% |
|
| Tremor |
71.4% |
| Shock |
14.3% |
| Urinary Retention |
14.3% |
|
